Cormorant Asset Management »

Korro Bio shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.0M 266k 33.87
2024-03-31 $48M 529k 90.00
2023-12-31 $25M 529k 47.93

More positions owned by Cormorant Asset Management

Moonlake Immunotherapeutics Class A Ord (MLTX)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Arcellx Common Stock (ACLX)
Vaxcyte (PCVX)
Longboard Pharmaceuticals In (LBPH)
Eyepoint Pharmaceuticals Com New (EYPT)
Rapport Therapeutics (RAPP)
Crinetics Pharmaceuticals In (CRNX)
Edgewise Therapeutics (EWTX)
Merus N V (MRUS)
Bridgebio Pharma (BBIO)
Insmed Com Par $.01 (INSM)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Janux Therapeutics (JANX)
Axsome Therapeutics (AXSM)

View all positions for Cormorant Asset Management

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Deep Track Capital
Citadel Advisors
Vanguard Group
BlackRock
Point72 Asset Management
Siren
BlackRock
Eventide Asset Management
Qiming U.S. Ventures Management
72 Investment Holdings
Cormorant Asset Management
Driehaus Capital Management
Schonfeld Strategic Advisors

View all funds holding Korro Bio